| ID | Sequence | Length | GC content |
|---|---|---|---|
| AUUGCCUGCUUCUCCCCACCCCCAAAUUAAGUUGCUUAGCAAGGGGGAA… | 3338 nt | 0.5704 | |
| AGUAAAUACGGAGAAUCACGUCGAACACCAGUGGCCCAGAUACUGUCGU… | 2292 nt | 0.4965 | |
| AGUCUCAUUGAGCCUGACUCGAGUAAUGAUUAACUGGCUGCCCGGAGCC… | 2385 nt | 0.4901 | |
| AUUGCCUGCUUCUCCCCACCCCCAAAUUAAGUUGCUUAGCAAGGGGGAA… | 3341 nt | 0.5705 |
The protein encoded by this gene is a nuclear protein that binds the E3 ubiquitin ligase SMURF2. Upon binding, this complex translocates to the cytoplasm, where it interacts with TGF-beta receptor type-1 (TGFBR1), leading to the degradation of both the encoded protein and TGFBR1. Expression of this gene is induced by TGFBR1. Variations in this gene are a cause of susceptibility to colorectal cancer type 3 (CRCS3). Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2010]
A study in mice demonstrated that the SMAD7 is a target of exosomal miR-21-5p, where its suppression by this miRNA delivered from traumatic brain injury patient-derived exosomes promotes osteogenic differentiation of human mesenchymal stem cells and enhances fracture healing in a femoral fracture model [Lin et al. DOI:10.1038/s12276-023-00956-8]. In a rat model of radiation-induced lung injury, the SMAD7 was identified as a predicted and validated target gene of miR-21, with its expression being negatively correlated with miR-21 and inhibited by miR-21 mimic transfection in rat lung type II pneumocyte cells [Xie et al. DOI:10.1186/1748-717X-9-111].